Complete remission of cutaneous and subcutaneous melanoma metastases of the scalp with imiquimod therapy

被引:17
|
作者
Heber, Giada [1 ]
Helbig, Doris [1 ]
Poenitzsch, Iris [1 ]
Wetzig, Tino [1 ]
Harth, Wolfgang [2 ]
Simon, Jan-Christoph [1 ]
机构
[1] Univ Clin Leipzig, Dept Dermatol Venereol & Allergol, Leipzig, Germany
[2] Vivantes Clin Friedrichshain, Dept Dermatol & Phlebol, Berlin, Germany
关键词
melanoma; imiquimod; immune therapy; IMMUNE-RESPONSE MODIFIER; MALIGNANT-MELANOMA; TOPICAL IMIQUIMOD; INTERLEUKIN-2;
D O I
10.1111/j.1610-0387.2009.07038.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Multiple cutaneous and subcutaneous melanoma metastases represent a therapeutic challenge. A 63-year-old man presented with multiple cutaneous and subcutaneous melanoma metastases on his right parieto-occipital region that appeared ten weeks after surgical excision of the primary tumor. Staging showed no further metastases. Because of the large area of cutaneous metastatic spread, the location and the limited possibility of a complete excision, we decided to begin immunomodulatory therapy with imiquimod applied for eight hours daily five days a week. After six weeks of imiquimod monotherapy, a partial remission of the cutaneous metastases had occurred. After 17 months, the remission of these metastases was complete. Four months later the patient is still free of cutaneous, visceral, cerebral and lymph node metastases.
引用
收藏
页码:534 / 536
页数:3
相关论文
共 50 条
  • [21] Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma
    Bong, AB
    Bonnekoh, B
    Franke, I
    Schön, MP
    Ulrich, J
    Gollnick, H
    DERMATOLOGY, 2002, 205 (02) : 135 - 138
  • [22] Complete remission of cutaneous satellite and in-transit metastases.: After intralesional therapy with interleukin-2 in two patients with malignant melanoma
    Pföhler, C
    Steinhäuser, S
    Wagner, A
    Ugurel, S
    Tilgen, W
    HAUTARZT, 2004, 55 (02): : 171 - 175
  • [23] Complete Remission of Metastatic Melanoma of the Scalp Following Treatment With Nivolumab Plus Relatlimab
    McMinn, Mary E.
    Brister, Kelly A.
    Orr, W. Shannon
    Sheehan, Natale T.
    Christopher, Wade O.
    AMERICAN SURGEON, 2024, 90 (08) : 2078 - 2079
  • [24] Complete regression of subcutaneous and cutaneous metastatic melanoma with high-dose intralesional interleukin 2 in combination with topical imiquimod and retinoid cream
    Garcia, Miki Shirakawa
    Ono, Yoko
    Martinez, Steve R.
    Chen, Steven L.
    Goodarzi, Heidi
    Phan, Tiffany
    Wehrli, Lisa N.
    Miyamura, Yoshinori
    Fung, Maxwell A.
    Maverakis, Emanual
    MELANOMA RESEARCH, 2011, 21 (03) : 235 - 243
  • [25] Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy
    Chang, E
    Rosenberg, SA
    JOURNAL OF IMMUNOTHERAPY, 2001, 24 (01): : 88 - 90
  • [26] First experiences with the topical immune response modifier imiquimod for the treatment of cutaneous melanoma metastases
    Steinmann, A
    Funk, JO
    Berger, T
    Maczek, C
    Schuler, G
    von den Driesch, P
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 589 - 589
  • [27] INTRANODULAR TREATMENT WITH BCG OF CUTANEOUS AND SUBCUTANEOUS METASTASES OF MALIGNANT-MELANOMA
    BALZARINI, GP
    CASCINELLI, N
    FONTANA, V
    VERONESI, U
    TUMORI JOURNAL, 1974, 60 (04): : 345 - 352
  • [28] Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil
    Florin, V.
    Vercambre-Darras, S.
    Piette, F.
    Mortier, L.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 (8-9): : 603 - 604
  • [29] Imiquimod enhances the effect of cryotherapy in the management of cutaneous melanoma metastases: A retrospective study of 20 patients
    Tolosa, Nancy Rivas
    Ortiz, Ariadna
    Toledo, Tomas
    Alcala, Rebeca
    Traves, Victor
    Soriano, Virtudes
    Requena, Celia
    Guillen, Carlos
    Marti, Rosa
    Nagore, Eduardo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB170 - AB170
  • [30] Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil
    Florin, Valerie
    Desmedt, Eve
    Vercambre-Darras, Sophie
    Mortier, Laurent
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (04) : 1641 - 1645